Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2014 Apr 23;20(8):1229–1237. doi: 10.1016/j.bbmt.2014.04.019

Table 4.

Multivariate Analysis of Predictors of BAL

Variable Hazard Ratio 95% Confidence Interval P Value
Age 1.056 1.012–1.101 .0122
Risk
 Average Reference (1.0)
 Poor 1.427 .802–2.540 .2262
Chronic GVHD .217 .030–1.585 .1321
Acute GVHD .066 .009–.485 .0076
Transplantation type
 MAC autoSCT Reference (1.0)
 MAC alloSCT 8.464 2.725–26.293 .0002
 RTC alloSCT 2.613 .751–9.083 .1309
T cell antibody
 None Reference (1.0)
 R-ATG .785 .417–1.478 .4531
 Alemtuzumab 1.223 .543–2.754 .6270

BAL indicates bronchoalveolar lavage; GVHD, graft-versus-host disease; MAC, myeloablative conditioning; autoSCT, autologous stem cell transplantation; alloSCT, allogeneic stem cell transplantation; RTC, reduced-toxicity conditioning; R-ATG, rabbit antithymocyte globulin.